Rocket Lab's Nasdaq-100 Countdown: KeyBanc Upgrade Collides With ARK's SpaceX Rotation
Published on 06/17/2026 at 16:53 | Redaktion boerse-global.de
Rocket Lab enters the final stretch before its Nasdaq-100 inclusion on June 22 with a starkly divided investor audience. While KeyBanc has just upgraded the stock to Overweight with a $135 target, ARK Investment used the same week to dump its Rocket Lab holdings and pile into SpaceX — a direct competitor according to the latter’s S-1 filing.
The contrasting moves crystallise the broader debate: Is Rocket Lab a maturing space champion backed by a $2.2 billion order book, or a growth story vulnerable to the gravitational pull of Elon Musk’s juggernaut?
Record Backlog Meets Recurring Revenue
The bull case leans heavily on the numbers. Rocket Lab posted a record Q1 2026 revenue of $200.3 million, a 63.5% surge year-on-year, while its backlog doubled to $2.2 billion. Among the contracts underpinning that pipeline are an $816 million US Space Force award and a $190 million deal for 20 hypersonic test launches. The company’s vertical integration — roughly 90% for the Electron rocket and 95% for satellite systems — gives it pricing power and supply-chain independence that rivals envy.
Analyst consensus from 21 firms sits at $102.76 per share, with 12 Buy ratings and three Strong Buys against just one Sell. Stifel raised its target from $110 to $132 on June 8, and KGI Securities initiated coverage at Neutral with a $105 target on June 11. KeyBanc’s upgrade on June 15, citing a structural undersupply of launch capacity that could last a decade, capped the recent wave of Wall Street endorsement.
Should investors sell immediately? Or is it worth buying Rocket Lab?
ARK Switches Horses
Yet on June 12 — the same day SpaceX went public — ARK Investment bought roughly 3.3 million SpaceX shares for about $444 million while selling 50,746 Rocket Lab shares worth roughly $5.8 million across its ARKQ and ARKX funds. The move was part of a broader rotation that also jettisoned AMD, Roku and Baidu. The symbolism is unambiguous: ARK sees SpaceX’s scale and reusable Falcon 9 as the superior long-term bet.
Rocket Lab isn’t standing still. Its own reusable Neutron rocket — targeting up to 13,000 kilograms to low Earth orbit — already has five commercial contracts signed, with a first flight scheduled for Q4 2026. A successful debut would directly challenge SpaceX’s Falcon 9 in the medium-lift market. The company is also a leading contender for NASA’s Mars Telecommunications Orbiter contract, potentially worth up to $700 million.
Operational Surprises and a Pushed-Back Launch
Operationally, the story remains busy if slightly delayed. The 90th Electron mission, “Ten Owl Of Ten,” originally set for June 18 from Launch Complex 1 in New Zealand, has been postponed for additional technical checks. It will carry a StriX SAR satellite for Japan’s Synspective under a long-term agreement covering 17 missions through 2030. Retail investors appear unfazed, given Electron’s strong reliability record.
A more intriguing development emerged from the HASTE program. The latest “Curveball” mission for the US Department of Defense unexpectedly reached a low Earth orbit of around 200 kilometres — a capability well beyond HASTE’s typical suborbital hypersonic testing remit. Analysts are parsing what this reveals about the vehicle’s real performance envelope, especially as Neutron development accelerates.
Index Inclusion and Price Support
The stock currently trades around €90.90 (or €90.20 in the secondary report’s quote), roughly 32-33% below its 52-week high of €133.80. On a year-to-date basis, it remains up nearly 40%. The 50-day moving average, at about €89.50, has provided near-term support.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
From June 22, Rocket Lab becomes one of five new additions to the Nasdaq-100, joining Astera Labs, CoreWeave, Nebius Group and Teradyne. More than 200 ETFs and index funds managing over $800 billion in assets will be forced buyers. The initial reaction to the announcement — a pre-market spike of over 8% that reversed the same day — suggested a classic “sell the news” pattern, but the mechanical flows from index-tracking products could provide a more sustained bid.
The immediate question is whether that forced buying can offset the sentiment drag from ARK’s high-profile rotation and any lingering disappointment from the mission delay. With a record backlog, a growing constellation of institutional endorsements, and a Neutron rocket waiting in the wings, Rocket Lab heads into its Nasdaq-100 debut as one of the most watched — and most debated — names in the space sector.
Ad
Rocket Lab Stock: New Analysis - 17 June
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
